Mar 29, 2023 | Awareness, Legal Update
As cannabis legalization gains traction across the United States, another psychoactive substance is making waves in the realm of mental health: psilocybin, the active compound found in certain species of mushrooms. While psilocybin is still illegal at the federal...
Mar 29, 2023 | Awareness, Research
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that affects millions of people worldwide. It is characterized by symptoms such as inattention, hyperactivity, and impulsivity. While there are various treatments available for...
Sep 16, 2022 | In the News
We are in the middle of a resurgence of research on psychedelic medicines and psychotherapy. Multiple federally approved clinical studies on psychedelics like psilocybin, MDMA, and other entheogens are currently in progress. The FDA has declared psilocybin and MDMA to...
Aug 29, 2022 | Patient Highlight
Receiving a diagnosis of a terminal illness shakes the entire family. Many patients faced with the idea of dying, undergo a storm of emotions including fear, anxiety, and depression. All of which can drastically reduce the quality of life for patients who don’t have...
Aug 22, 2022 | Legal Update
Utah’s Mental Illness Psychotherapy Drug Task Force is active and operating, but what is it? What is the task force doing? Who is on the task force, and why was it formed in the first place? You can find the answers to all of these questions below as we take a closer...
